| SCH 727965 in Patients With Advanced Breast and Lung Cancers (Study P04716) (NCT00732810) | Merck Sharp & Dohme LLC | 2008-07-01 |
| Ultrasound Elastography of Breast Lesions (NCT00716482) | SuperSonic Imagine | 2008-07-01 |
| Study of Autologous Fat Enhanced w/ Regenerative Cells Transplanted to Reconstruct Breast Deformities After Lumpectomy (NCT00616135) | Cytori Therapeutics | 2008-06-01 |
| Epirubicin or Not in Patients With TOP2A (Topoisomerase (DNA) II Alpha (170kD)) Normal Early Breast Cancer (NCT00689156) | Danish Breast Cancer Cooperative Group | 2008-06-01 |
| Research Of Quality Of Life And Safety Outcomes Of Postmenopausal Breast Cancer Patients Switching From Tamoxifen Therapy To Aromatase Inhibitor Therapy (NCT00784888) | Pfizer | 2008-06-01 |
| Use of Bone Scintigraphy, CT and MRI in Breast Cancer (NCT00682253) | University of Aarhus | 2008-05-01 |
| Capecitabine vs. S-1 in Unresectable or Recurrent Breast Cancer (NCT00438100) | Japan Breast Cancer Research Network | 2008-04-01 |
| Tamoxifen-RAD001 Versus Tamoxifen Alone in Patients With Anti-aromatase Resistant Breast Metastatic Cancer (NCT01298713) | ARCAGY/ GINECO GROUP | 2008-03-01 |
| Randomized Study Evaluating Ixabepilone Plus Capecitabine or Docetaxel Plus Capecitabine in Metastatic Breast Cancer (NCT00546364) | R-Pharm | 2008-02-01 |
| Guarana (Paullinia Cupana) for Breast Cancer Chemotherapy-related Fatigue (NCT01043913) | Faculdade de Medicina do ABC | 2008-02-01 |
| The Synergism Or Long Duration (SOLD) Study (NCT00593697) | Finnish Breast Cancer Group | 2008-01-01 |
| Healing Touch and Health-Related Quality of Life in Women With Breast Cancer Receiving Radiation Therapy (NCT00612443) | University of Wisconsin, Milwaukee | 2008-01-01 |
| A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886) (NCT00600496) | AstraZeneca | 2007-12-14 |
| A Study of Ispinesib in Metastatic Breast Cancer (NCT00607841) | Cytokinetics | 2007-12-01 |
| Registry of Mastectomy for Breast Cancer Risk Reduction (NCT00555503) | Georgetown University | 2007-11-01 |
| Choline Quantification in Breast Cancer by MRS (NCT00201487) | Norwegian University of Science and Technology | 2007-11-01 |
| The Clinical and Economic Impact of Pharmacogenomic Testing for Tamoxifen Metabolism in Postmenopausal Women Receiving Tamoxifen for Prevention of Recurrent Breast Cancer (NCT00830973) | Medco Health Solutions, Inc. | 2007-10-01 |
| A Study to Determine the Management of Palmar-plantar Erythrodysesthesia (PPE) in Patients With Metastatic Ovarian or Breast Cancer Treated With Caelyx (Study P05020) (NCT00746694) | Merck Sharp & Dohme LLC | 2007-10-01 |
| A Phase 1/2 Study of HKI-272 (Neratinib) in Combination With Paclitaxel (Taxol) in Subjects With Solid Tumors and Breast Cancer (NCT00445458) | Puma Biotechnology, Inc. | 2007-09-11 |
| Phase II Trial of Oxaliplatin in Combination With S-1(SOX) in Patients With Recurrent or Metastatic Breast Cancer (NCT00527930) | Seoul National University Hospital | 2007-09-01 |
| Efficacy And Safety Of Sunitinib In Women With Advanced Breast Cancer (NCT00471276) | Pfizer | 2007-08-01 |
| A Study Of Docetaxel Or Docetaxel Plus PF-3512676 To Treat Patients With Advanced Breast Cancer. (NCT00471159) | Pfizer | 2007-08-01 |
| Gene Expression Profile of Breast Cancer Samples After Vitamin D Supplementation (NCT00926315) | University of Sao Paulo General Hospital | 2007-07-01 |
| Study to Assess The Efficacy and Safety of a PARP Inhibitor For The Treatment of BRCA-positive Advanced Breast Cancer (NCT00494234) | AstraZeneca | 2007-06-15 |
| A Clinical Trial Assessing Efficacy and Safety of Sunitinib and Exemestane in Patients With ER [Estrogen Receptor] + and/or PgR [Progesterone Receptor] + Breast Cancer (NCT00417885) | Pfizer | 2007-06-01 |
| An Efficacy Study of Trabectedin in the Treatment of Participants With Specific Subtypes of Metastatic Breast Cancer (NCT00580112) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2007-06-01 |
| Treatment of Larotaxel/Docetaxel, +/- Trastuzumab, After Anthracycline-cyclophosphamide in Breast Cancer Patients (NCT00485979) | Sanofi | 2007-06-01 |
| Breast Mammogram and Tissue Study (NCT00475761) | National Cancer Institute (NCI) | 2007-05-11 |
| Trial of Tomotherapy in Breast Cancer (NCT00459628) | Vrije Universiteit Brussel | 2007-05-01 |
| Antiestrogen vs Aromatase Inhibitor After Adjuvant Chemotherapy for Breast Cancer (NCT00437359) | Japan Breast Cancer Research Network | 2007-05-01 |
| Comparison of Sevoflurane and Isoflurane Anesthesia for Benign Breast Tumor Excision (NCT00575354) | Nanjing Medical University | 2007-03-01 |
| Pilot Study of the Safety & Efficacy of Two Docetaxel-Based Regimens Plus Bevacizumab for the Adjuvant Treatment of Subjects With Node Positive or High Risk Node Negative Breast Cancer (NCT00446030) | Sanofi | 2007-03-01 |
| Pegylated Liposomal Doxorubicin (Caelyx(R)) as Monotherapy in Elderly Patients With Locally Advanced and/or Metastatic Breast Cancer (Study P05059) (NCT00604968) | Merck Sharp & Dohme LLC | 2007-02-07 |
| Study Of Sunitinib In Combination With Docetaxel Vs Docetaxel In Patients With Advanced Breast Cancer (NCT00393939) | Pfizer | 2007-02-01 |
| Study Of CP-751,871 In Combination With Exemestane In Postmenopausal Women With Hormone Receptor Positive Advanced Breast Cancer (NCT00372996) | Pfizer | 2007-02-01 |
| Clinical Evaluation of OSNA Breast Cancer System to Test Sentinel Lymph Nodes From Patients With Breast Cancer (NCT01136369) | Sysmex America, Inc. | 2007-02-01 |
| Proteomic Analysis of HLA Complex in Solid Cancers: Breast, Ovary, Colon, Rectum, Stomach, and Pancreas (NCT00419627) | Hillel Yaffe Medical Center | 2007-02-01 |
| Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast Cancer (NCT00426530) | Novartis Pharmaceuticals | 2007-02-01 |
| A Study Of Sunitinib In Combination With Capecitabine Compared With Capecitabine In Patients With Breast Cancer (NCT00435409) | Pfizer | 2007-02-01 |
| Body Image and Psychosocial Functioning in Women With Breast Cancer: Can We Fix What We've Broken? (NCT00418444) | University Health Network, Toronto | 2007-01-01 |
| BIBW 2992 and Letrozole in Hormonoresistant Metastatic Breast Cancer (NCT00708214) | Boehringer Ingelheim | 2007-01-01 |
| Regional Anesthesia and Breast Cancer Recurrence (NCT00418457) | The Cleveland Clinic | 2007-01-01 |
| A Study of AMG 706 or Bevacizumab, in Combination With Paclitaxel Chemotherapy, as Treatment for Breast Cancer (NCT00356681) | Amgen | 2006-12-01 |
| Use of Hair to Diagnose Breast Cancer (NCT00419679) | Fermiscan Ltd | 2006-12-01 |
| Vaginal Testosterone Cream For Atrophic Vaginitis in Women Taking Aromatase Inhibitors for Breast Cancer. (NCT01122342) | University of Vermont | 2006-12-01 |
| Docetaxel Followed by Capecitabine Versus Concomitant Docetaxel/Capecitabine for Early Stage Breast Cancer (NCT00415285) | Georgia Center for Oncology Research & Education | 2006-12-01 |
| Enzastaurin For Breast Cancer Patients Who Previously Received an Anthracycline and a Taxane Chemotherapy (NCT00386087) | Eli Lilly and Company | 2006-11-01 |
| A Clinical Trial Comparing Efficacy And Safety Of Sunitinib And Capecitabine (NCT00373113) | Pfizer | 2006-11-01 |
| An Open Label Phase II Trial of BIBW 2992 in Patients With HER2-negative Metastatic Breast Cancer (NCT00425854) | Boehringer Ingelheim | 2006-11-01 |
| A Study Of SU011248 Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel In Patients With Advanced Breast Cancer (NCT00373256) | Pfizer | 2006-11-01 |
| The Influence of Breast Cancer Risk and Risk Perception on Lifestyle Behaviors Among Women With a Family History: A Mixed Method Approach (NCT00393406) | National Institute of Environmental Health Sciences (NIEHS) | 2006-10-24 |
| Randomized Controlled Trial Comparing MBSR to SET in Breast Cancer Patients (NCT00390169) | Canadian Breast Cancer Research Alliance | 2006-10-01 |
| Chlorhydrate of Ropivacaine and Breast Cancer Surgery (NCT00370240) | Institut Curie | 2006-09-01 |
| Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for Apoptosis (NCT00243685) | Pierian Biosciences | 2006-09-01 |
| Evaluation of the Cryotherapy in the Prevention of Nails Toxicity Induced by Taxotere® in Breast or Prostate Cancer (NCT00925418) | Institut Paoli-Calmettes | 2006-09-01 |
| Trastuzumab, Cyclophosphamide, and an Allogeneic GM-CSF-secreting Breast Tumor Vaccine for the Treatment of HER-2/Neu-Overexpressing Metastatic Breast Cancer (NCT00399529) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2006-09-01 |
| Phase 1 Dose Escalation Study of SN2310 Injectable Emulsion in Patients With Advanced Solid Tumors (NCT00385177) | Achieve Life Sciences | 2006-09-01 |
| Phase II Trial of BIBW 2992 in Patients With HER2-positive Metastatic Breast Cancer After Failure of Trastuzumab Therapy (NCT00431067) | Boehringer Ingelheim | 2006-09-01 |
| Study Evaluating HKI-272 (Neratinib) In Subjects With Advanced Breast Cancer (NCT00300781) | Puma Biotechnology, Inc. | 2006-08-04 |
| Testing of Different Methods for Determining Whether Breast Cancer Has Spread to the Lymph Nodes (NCT00360152) | Washington University School of Medicine | 2006-08-01 |
| Study Of SU011248 In Combination With Docetaxel In Patients With Metastatic Breast Cancer (NCT00291577) | Pfizer | 2006-07-01 |
| Safety and Efficacy Study of the Trifunctional Antibody Ertumaxomab to Treat Patients With Advanced or Metastatic Breast Cancer (NCT00351858) | Neovii Biotech | 2006-07-01 |
| XRP9881 in Combination With Trastuzumab in Metastatic Breast Cancer (NCT00386685) | Sanofi | 2006-07-01 |
| Spect Analysis of Cardiac Perfusion Changes After Whole Breast/Chest Wall Radiation Therapy With ABC (NCT00321048) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2006-06-01 |
| Ultrasound Targeting for the Lumpectomy Cavity (NCT00583843) | University of Iowa | 2006-06-01 |
| Involvement of Endogenous Digitalis-like Compounds in Breast Cancer (NCT00310882) | Hadassah Medical Organization | 2006-05-01 |
| Study Evaluating SKI-606 (Bosutinib) In Subjects With Breast Cancer (NCT00319254) | Pfizer | 2006-05-01 |
| Mammosite Breast Brachytherapy Optimization in the Treatment of Breast Carcinoma (NCT00611624) | Yale University | 2006-05-01 |
| Study Of The Efficacy And Safety Of SU-014813 In Patients With Metastatic Breast Cancer (NCT00322517) | Pfizer | 2006-04-01 |
| Detection and/or Evaluation of Dense Breast Abnormalities Using Tomosynthesis and Digital Mammography (NCT00722059) | University of Michigan | 2006-04-01 |
| Phase II Study With Trastuzumab + Paclitaxel in Locally Advanced HER2+ Tumors or Epirubicin + Taxotere in HER2- Tumors (NCT02307227) | Centro di Riferimento Oncologico - Aviano | 2006-04-01 |
| Magnetic Resonance Imaging (MRI) Correlation to Standard of Care Imaging and Pathology Correlation in Breast Carcinoma (NCT00291304) | AHS Cancer Control Alberta | 2006-03-01 |
| Prayer as a Possible Adjuvant Treatment for Breast Cancer (NCT00519545) | Southwestern Regional Medical Center | 2006-03-01 |
| Tolerance and Pharmacokinetics With Capecitabine 5 Out of 7 Days Regimen (NCT00324610) | Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie | 2006-03-01 |
| Partial Breast Irradiation (PBI) for Selected Patients With Early Breast Cancer (NCT00325598) | Washington University School of Medicine | 2006-02-14 |
| Open Label Study Of SU011248 In Combination With Trastuzumab For Patients With Metastatic Breast Cancer (NCT00243503) | Pfizer | 2006-02-01 |
| Phase 3 Study of Acupression's Bracelets in Nausea and Vomiting Induced by FEC100 Chemotherapy's Sort. (NCT00268125) | Institut Claudius Regaud | 2006-02-01 |
| The MONET - Study: MR Mammography of Nonpalpable Breast Tumors (NCT00302120) | UMC Utrecht | 2006-02-01 |
| Weekly vs. Every 2 Week vs. Every 3 Week Administration of ABI-007 (Abraxane)/Bevacizumab Combination in Metastatic Breast Cancer (NCT00281528) | Celgene | 2006-02-01 |
| A Study of the Effects of Inhibiting Platelet Function on Circulating Cancer Cells in Breast Cancer Patients (NCT00263211) | Washington University School of Medicine | 2006-01-01 |
| The Diagnostic Efficacy of Computer-Aided Detection (CAD) in Full-Field Digital Mammography (FFDM)- A Prospective Study (NCT00173303) | National Taiwan University Hospital | 2006-01-01 |
| Vinflunine Plus Trastuzumab in Human Epidermal Growth Factor Receptor 2 (HER2neu) Over-Expressing Metastatic Breast Cancer (NCT00284180) | SCRI Development Innovations, LLC | 2006-01-01 |
| Study Of SU011248 Versus Chemotherapy For Patients With Previously Treated Triple Receptor Negative Breast Cancer (NCT00246571) | Pfizer | 2006-01-01 |
| Does a Single Steroid Injection Reduce the Formation of Postmastectomy Seroma (NCT00307606) | Herlev Hospital | 2005-12-01 |
| Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Breast Cancer (NCT00288249) | Bayer | 2005-12-01 |
| Treatment and Survival Continuation Study of Atamestane Plus Toremifene vs Letrozole in Advanced Breast Cancer (NCT00267553) | Intarcia Therapeutics | 2005-11-01 |
| High Dose Vit D Musculoskeletal Symptoms & Bone Density in Anastrozole-Treated Breast Cancer With Marginal Vit D Status (NCT00263185) | Washington University School of Medicine | 2005-11-01 |
| A Study to Determine the Clinical Significance of Molecular Detection of Breast Cancer in the Blood of Stage IV Breast Cancer Patients (NCT00355316) | Washington University School of Medicine | 2005-11-01 |
| An Effective and Compliance Regimen of Paclitaxel Plus Cisplatin to Treat Metastatic Breast Cancer (NCT00270569) | Far Eastern Memorial Hospital | 2005-10-01 |
| Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells (NCT00353483) | Washington University School of Medicine | 2005-09-14 |
| Simultaneous Study of Gemcitabine-Docetaxel Combination Adjuvant Treatment, as Well as Extended Bisphosphonate and Surveillance-Trial (NCT02181101) | Ludwig-Maximilians - University of Munich | 2005-09-01 |
| Study Of SU011248 In Combination With Paclitaxel In Patients With Metastatic Breast Cancer (NCT00174434) | Pfizer | 2005-09-01 |
| Characterization of Brain Metastases (NCT00184275) | Norwegian University of Science and Technology | 2005-05-01 |
| Aromasin Vs Arimidex Study As Initial Hormonal Therapy In Postmenopausal Women With Advanced/Recurrent Breast Cancer (NCT00143390) | Pfizer | 2005-04-01 |
| Therapy With Abraxane and 5-Fluorouracil, Epirubicin, Cyclophosphamide (FEC) for Patients With Breast Cancer (NCT00110695) | NSABP Foundation Inc | 2005-04-01 |
| A Research Study of CP-724,714 in Patients With HER2 Overexpressing Metastatic Breast Cancer (NCT00102895) | Pfizer | 2005-04-01 |
| The Study of Infrared Imaging on Breast Cancer (NCT00166998) | National Taiwan University Hospital | 2005-03-01 |
| Near Infrared/ Ultrasound Dual Modal Imaging for Breast Cancer Diagnosis (NCT00499980) | Ohio State University | 2005-03-01 |
| A Study to Evaluate the Safety of Adjuvant Treatment With Exemestane Following Previous Treatment With Tamoxifen in Postmenopausal Women With Estrogen Sensitive Primary Breast Cancer (NCT00649090) | Pfizer | 2005-03-01 |
| Proton Magnetic Resonance Spectroscopy of Normal Breast Tissues in Women Volunteers (NCT00155090) | National Taiwan University Hospital | 2005-01-01 |